Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-003658
Filing Date
2015-08-14
Accepted
2015-08-13 21:45:18
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 572919
2 ex31-1.htm EX-31.1 18605
3 ex31-2.htm EX-31.2 19487
4 ex32-1.htm EX-32.1 9750
  Complete submission text file 0001493152-15-003658.txt   3858139

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE trgm-20150630.xml EX-101.INS 703273
6 XBRL SCHEMA FILE trgm-20150630.xsd EX-101.SCH 46685
7 XBRL CALCULATION FILE trgm-20150630_cal.xml EX-101.CAL 49594
8 XBRL DEFINITION FILE trgm-20150630_def.xml EX-101.DEF 155351
9 XBRL LABEL FILE trgm-20150630_lab.xml EX-101.LAB 348514
10 XBRL PRESENTATION FILE trgm-20150630_pre.xml EX-101.PRE 245717
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-Q | Act: 34 | File No.: 000-53071 | Film No.: 151052328
SIC: 2834 Pharmaceutical Preparations